Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasite researchers win Nobel Prize
Mosquito
"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases” - Nobel assembly.
Awarded for work on malaria and roundworm therapies

The 2015 Nobel Prize in physiology or medicine has been awarded to three researchers for their contributions in developing novel therapies against malaria and roundworm parasite infection.

According to the Guardian, William Campbell and Satoshi Omura were awarded for their work on a therapy against roundworm, shared jointly with Tu Youyou, for a therapy against malaria.

In a statement published by Healio, the Nobel assembly said: "Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world’s poorest populations and represent a huge barrier to improving human health and well-being.

"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases.”

Tu discovered the life saving malaria ingredient by extracting the active ingredient of a traditional herbal medicine.

The component, later called artemisinin, targets the parasites during an early stage of their development. It is highly effective in both animals and humans, and is estimated to reduce the number of deaths caused by malaria by over 20 per cent.

Satoshi Omura's research explored the isolation and culture of several new strains of Streptomyces, which are known to have antibacterial qualities.

These were later acquired by William Campbell, who discovered that one of the cultures was effective against parasite infection in animals.  

This led to the discovery of avermectin and its derivative, Mectizan, which has contributed to the global fight against parasitic diseases such as river blindness and onchocerciasis.

Christopher Plowe, president of the American Society of Tropical Medicine and Hygiene, said:  “This year’s Prize recognises scientists who isolated compounds from bacteria and plants and developed them into drugs that have saved countless lives from malaria and prevented millions of cases of blindness and disfiguring swelling from parasitic worms worldwide.

“These three scientists have had a massive positive impact on global health. This was a great choice by the Nobel Committee.”

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com